NYSE:MTD - Mettler-Toledo International Stock Price, Price Target & More

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International Inc. (NYSE:MTD) announced its quarterly earnings data on Thursday, May, 3rd. The medical instruments supplier reported $3.74 earnings per share for the quarter, beating the consensus estimate of $3.73 by $0.01. The medical instruments supplier had revenue of $660.82 million for the quarter, compared to analyst estimates of $651.87 million. Mettler-Toledo International had a net margin of 13.50% and a return on equity of 90.70%. The business's quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.34 earnings per share. View Mettler-Toledo International's Earnings History.

Mettler-Toledo International is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Mettler-Toledo International.

Mettler-Toledo International issued an update on its second quarter earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $4.55 to $4.60 for the period, compared to the Thomson Reuters consensus estimate of $4.54.

11 brokerages have issued 12 month target prices for Mettler-Toledo International's shares. Their predictions range from $568.00 to $692.00. On average, they expect Mettler-Toledo International's share price to reach $631.1111 in the next year. View Analyst Ratings for Mettler-Toledo International.

Some companies that are related to Mettler-Toledo International include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

Media stories about MTD stock have been trending somewhat positive this week, according to Accern Sentiment. The research firm scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mettler-Toledo International earned a coverage optimism score of 0.07 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 45.67 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Mettler-Toledo International's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.19%), Baillie Gifford & Co. (2.43%), Fiera Capital Corp (2.36%), Bamco Inc. NY (2.36%), Massachusetts Financial Services Co. MA (2.16%) and Franklin Resources Inc. (2.01%). Company insiders that own Mettler-Toledo International stock include Christian Magloth, Francis A Contino, Hans Ulrich Maerki, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Richard D Francis, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Institutional Ownership Trends for Mettler-Toledo International.

MTD stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, OppenheimerFunds Inc., Thrivent Financial for Lutherans, Northern Trust Corp, BlackRock Inc., Federated Investors Inc. PA, Ownership Capital B.V. and Bamco Inc. NY. Company insiders that have sold Mettler-Toledo International company stock in the last year include Christian Magloth, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Insider Buying and Selling for Mettler-Toledo International.

MTD stock was purchased by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Westfield Capital Management Co. LP, Natixis, Toronto Dominion Bank, Millennium Management LLC, FIL Ltd, Ontario Teachers Pension Plan Board and Barclays PLC. View Insider Buying and Selling for Mettler-Toledo International.

Shares of MTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MTD stock can currently be purchased for approximately $579.65.

Mettler-Toledo International has a market capitalization of $14.86 billion and generates $2.73 billion in revenue each year. The medical instruments supplier earns $375.97 million in net income (profit) each year or $17.57 on an earnings per share basis. Mettler-Toledo International employs 15,400 workers across the globe.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The medical instruments supplier can be reached via phone at 614-438-4511 or via email at [email protected]